Literature DB >> 22990051

Soluble inflammation markers in nasal lavage from CF patients and healthy controls.

Natalie Beiersdorf1, Matthias Schien, Julia Hentschel, Wolfgang Pfister, Udo R Markert, Jochen G Mainz.   

Abstract

BACKGROUND: CF sinonasal and bronchial mucosa reveal identical ion channel defects. Nasal Lavage (NL) allows non-invasive repeated sampling of airway surface liquid. We compared inflammatory mediators in NL from CF-patients and healthy controls, and in CF in relation to sinonasal pathogen colonization.
METHODS: From 40 CF-patients (mean age 21.8yrs, SD 11.8yrs.) and 52 healthy controls (mean age 31.9yrs., SD 13.7yrs.) NL-fluid (10ml/nostril) concentrations of MPO, IL-8, IL-17A, sICAM-1, IL-1β, IL-6, TNF-α, IL-10 and IL-5 were determined using cytometric bead arrays for flow cytometry.
RESULTS: CF-patients showed significantly higher MPO-concentrations in NL-fluid and higher IL-8-levels (n.s.) than controls. MPO, IL-8, IL-17A, sICAM-1, IL-1β and IL-6 were significantly more often detectable in CF-patients than in controls. CF-patients with S. aureus colonization in both upper and lower airways had significantly elevated MPO and IL-8 levels in NL-fluid compared to S. aureus negatives.
CONCLUSION: NL-fluid differed substantially between CF-patients and healthy controls with most promising results for IL-8 and MPO, a primarily in CF-NL assessed mediator. Further studies are required to assess effects of sample collection and processing on concentrations of inflammatory markers and to evaluate potentials of NL analysis in research and clinical routine.
Copyright © 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990051     DOI: 10.1016/j.jcf.2012.08.015

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  8 in total

1.  Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis.

Authors:  Rebeca Passarelli Mantovani; Angela Sandri; Marzia Boaretti; Gloria Burlacchini; Veronica Li Vigni; Mattia Scarazzai; Paola Melotti; Caterina Signoretto; Maria M Lleo
Journal:  ERJ Open Res       Date:  2020-08-25

2.  Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.

Authors:  Jochen G Mainz; Andrea Gerber; Michael Lorenz; Ruth Michl; Julia Hentschel; Anika Nader; James F Beck; Mathias W Pletz; Andreas H Mueller
Journal:  Case Rep Infect Dis       Date:  2015-03-18

3.  Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy.

Authors:  Ulrike Müller; Julia Hentschel; Wibke K Janhsen; Kerstin Hünniger; Uta-Christina Hipler; Jürgen Sonnemann; Wolfgang Pfister; Klas Böer; Thomas Lehmann; Jochen G Mainz
Journal:  Mediators Inflamm       Date:  2015-06-21       Impact factor: 4.711

4.  Inflammation, infection, and allergy of upper airways: new insights from national and real-world studies.

Authors:  Attilio Varricchio; Ignazio La Mantia; Francesco Paolo Brunese; Giorgio Ciprandi
Journal:  Ital J Pediatr       Date:  2020-02-10       Impact factor: 2.638

5.  IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbations.

Authors:  George M Solomon; Carla Frederick; Shaoyan Zhang; Amit Gaggar; Tom Harris; Bradford A Woodworth; Chad Steele; Steven M Rowe
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

6.  Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.

Authors:  Ruth K Michl; Julia Hentschel; Christiane Fischer; James F Beck; Jochen G Mainz
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

7.  Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.

Authors:  Julia Hentschel; Manuela Jäger; Natalie Beiersdorf; Nele Fischer; Franziska Doht; Ruth K Michl; Thomas Lehmann; Udo R Markert; Klas Böer; Peter M Keller; Mathias W Pletz; Jochen G Mainz
Journal:  BMC Pulm Med       Date:  2014-05-13       Impact factor: 3.317

8.  Feasibility of flow cytometry in the rhinologist's clinic.

Authors:  Attilio Varricchio; Gianfranco Tajana; Catello Tommasino; Enrico Melillo; Salvatore Camerlingo; Ivan Rosolino; Francesco Avvisati; Ignazio La Mantia; Alfonso Maria Varricchio; Giorgio Ciprandi
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-07-31       Impact factor: 2.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.